Dr. Kayvan Kamali, M.D.
What this data tells you about Dr. Kamali
Dr. Kayvan Kamali is a rheumatology specialist in Longview, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kamali performed 7,086 Medicare services across 1,518 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kamali received a total of $35,771 from 43 pharmaceutical and/or device companies across 1672 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kamali is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 3,600 | $18 | $45 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,621 | $83 | $166 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
779 | $1 | $30 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
233 | $60 | $114 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
224 | $36 | $511 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
206 | $10 | $43 |
| X-ray of entire middle and lower spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the entire middle and lower spine to visualize the bones and structures in these areas. |
87 | $45 | $255 |
| New patient office visit, complex (60-74 min) | 84 | $147 | $346 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
70 | $97 | $642 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
58 | $52 | $246 |
| MRI of arm without contrast An MRI scan of the arm that uses magnetic fields and radio waves to create detailed images of internal structures without the use of contrast dye. |
40 | $166 | $1,858 |
| MRI of arm joint, without contrast An MRI scan uses magnetic fields and radio waves to create detailed images of the arm joint. This specific procedure is performed without the use of a contrast dye. |
39 | $84 | $2,109 |
| Injection, methylprednisolone acetate, 40 mg | 26 | $6 | $30 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
19 | $9 | $40 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kamali is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 13% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kamali experienced with denosumab injection (prolia/xgeva)?
Does Dr. Kamali receive payments from pharmaceutical companies?
How do Dr. Kamali's costs compare to other rheumatologists in Longview?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology